SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Brera Holdings Plc engages in the business of football division progression, global football player transfer service, sponsorship services, football school services, and consulting services on football projects. The company was founded on June 30, 2022 and is headquartered in Dublin, Ireland.

Brera Holdings PLC - Ordinary Shares - Class B

Brera Holdings PLC

BREA is trending due to its planned rebranding as Solmate, a Solana-backed digital asset treasury, fueled by a substantial private investment, with the community actively debating its potential for further gains or a significant pullback. Discussions include comparisons to similar stocks and speculation about short squeezes, float size, and potential after-hours movement. Some traders express concerns about dilution and caution against bag holding.

FedEx Corp. is a holding company, which engages in the provision of transportation, e-commerce, business services, and business solutions. It operates through the following segments: FedEx Express, FedEx Freight, Corporate, Other, and Eliminations. The FedEx Express segment offers transportation and delivery services. The FedEx Freight segment refers to freight transportation services to business and residences. The FedEx Services segment includes sales, marketing, information technology, communications, customer service, technical support, billing and collection services, and certain back-office functions that support the company's operating segments. The Corporate, Other, and Eliminations segment is involved in the corporate headquarters costs for executive officers and certain legal and finance functions, as well as certain other costs and credits not attributed to the firm's core business. The company was founded by Frederick Wallace Smith on June 18, 1971, and is headquartered in Memphis, TN.

Fedex Corp

FedEx ($FDX) is trending following its Q1 earnings release, which featured a better-than-expected EPS and revenue. Despite the earnings beat, the stock dipped in after-hours trading as community members discuss the company's soft guidance and concerns around global trade and tariffs. Some traders are speculating about a potential short squeeze and monitoring the upcoming conference call for further insights.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co.

Disney is trending amid discussions around free speech and potential boycotts related to the removal of Jimmy Kimmel's show, sparking debates over political polarization and censorship. The community is divided, with some supporting Disney's decision and others criticizing it as an attack on free speech. Broader conversations include the company's financial performance, streaming strategy, and the impact of political stances on its brand.

United Parcel Service, Inc. is a package delivery company, which engages in the provision of global supply chain management solutions. It operates through the following segments: U.S. Domestic Package, International Package, and Supply Chain Solutions. The U.S. Domestic Package segment includes time-definite delivery of letters, documents, and packages. The International Package segment focuses on delivery and shipments in Europe, Asia, the Indian sub-continent, the Middle East, Africa, Canada, and Latin America. The Supply Chain Solutions is involved in forwarding, logistics, Coyote, Marken, and UPS Mail Innovations. The company was founded by James E. Casey and Claude Ryan on August 28, 1907 and is headquartered in Atlanta, GA.

United Parcel Service, Inc. - Ordinary Shares - Class B

United Parcel Service, Inc.

UPS is trending as investors assess the potential impact of FedEx's earnings and the ending of tariff exemptions. The community is actively discussing the stock's attractive dividend yield and speculating on a potential bottom, while also weighing concerns about declining volumes and the risk of a dividend cut. Some traders are noting the stock's oversold condition and multi-year lows, sparking debates about whether it represents a value opportunity or a value trap.

Lennar Corp. engages in the provision of real estate related financial and investment management services. It operates through the following segments: Homebuilding, Financial Services, Multifamily, and Lennar Other. The Homebuilding segment refers to the construction and sale of single-family attached and detached homes and the purchase, development, and sale of residential land directly and through entities. The Financial Services segment focuses on mortgage financing, title, and closing services for buyers. The Multifamily segment is involved in the development, construction, and property management of multifamily rental properties. The Lennar Other segment includes funds, asset management platform, and strategic investments in technology companies. The company was founded in 1954 and is headquartered in Miami, FL.

Lennar Corp. - Ordinary Shares - Class A

Lennar Corp.

Lennar Corp. is trending as investors closely monitor upcoming earnings and anticipate potential impacts from housing market dynamics and interest rate fluctuations. Community discussions revolve around whether Lennar can maintain margins amid affordability challenges and if the Millrose spin-off will affect the stock's performance. Analysts have mixed views, with some lowering price targets while others remain optimistic about Lennar's strategic positioning.

༼ つ ◕_◕ ༽つ gib is a meme coin on Hedera, inspired by the classic copy pasta meme of persistence and community. Born from the viral 2013 Dota 2 Diretide event, gib embodies the power of collective action. As one of the first ASCII-named tokens on-chain, gib merges meme culture with blockchain innovation, helping users explore Hedera, crypto, and tech in a fun, engaging way. ༼ つ ◕_◕ ༽つ gib knowledge

GIB.X is trending as a meme coin on the Hedera network, drawing comparisons to PENGU and DOGE, with the community highlighting its small market cap and potential for significant growth. Many community members emphasize GIB's strong community, meme potential, and the backing of the Hedera Foundation as reasons for its bullish sentiment. The coin is also being discussed in the context of the broader Hedera (HBAR) ecosystem, with some seeing it as a gateway for new users.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending as discussions revolve around Panasonic's anode-free solid-state battery announcement and its potential connection to QS and Tesla. The community speculates on partnerships and licensing deals, with some questioning revenue and commercialization timelines. Bullish sentiment is fueled by potential technological breakthroughs, while skeptics remain cautious.

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

Cleanspark is trending as investors discuss its potential pivot towards AI and high-performance computing following recent CEO comments. The community is watching key resistance levels, with bullish traders calling it undervalued compared to peers like IREN and CIFR. Some are anticipating a short squeeze due to high short interest and are closely monitoring volume and option activity.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending due to strong revenue growth, particularly with Recorlev, leading to raised full-year revenue guidance, prompting community discussion around profitability and potential buyouts. Investors are impressed by the company's trajectory, with some anticipating further gains and analysts possibly adjusting price targets. Community members are highlighting the increased value of Recorlev and the potential for the company's technology.

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.

Nektar Therapeutics

Nektar Therapeutics ($NKTR) is trending due to promising clinical data for its eczema treatment, rezpegaldesleukin, sparking speculation about its potential to compete with existing therapies and a possible buyout. The community is buzzing about the drug's unique mechanism and analyst upgrades, while also anticipating updates on a lawsuit with Eli Lilly and potential future data readouts. Some traders are also noting that short sellers may be trying to capitalize on the hype.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Lucid Capital🏁 $UNCY Buy-$12 and said &quot;We are initiating coverage of Unicycive with a Buy rating and a $12/share 12-month Price Target&quot; - &quot;We estimate that OLC could capture &gt;$1.3B in peak sales in the US within two years after launch in 2025&quot; 
$TAK $SNY $ARDX AKBA $FMS 
Lucid Capital additionally said in its initiation report:

Kirk

Kari Lipponen

Larry Black

traderhong

Benchmark reiterated $UNCY Speculative Buy-$3. 
$TAK $SNY $ARDX $AKBA FMS  
Benchmark said in their note to investors: 
&quot;Unicycive is currently awaiting FDA approval for its first product candidate, Oxylanthanum Carbonate, which is anticipated later this year. We are updating our model for the 1Q filings with no change to our forward expectations. 
 
In November, the company announced that the FDA accepted its NDA of Oxylanthanum Carbonate (OLC) for the treatment of hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis, and set a PDUFA date of June 28, 2025. 
 
Benchmark additionally said:

StockTwits Web

Unicycive Therapeutics Inc

Takeda Pharmaceutical Co Ltd (ADR)

Sanofi-Aventis

Ardelyx Inc

Akebia Therapeutics Inc.

Quantumup

H.C. Wainwright reiterated $UNCY Buy-$9 
$TAK $SNY $ARDX $AKBA FMS 
H.C. Wainwright said in its note: &quot;On June 10, Unicycive management announced that the FDA has identified a cGMP compliance-related deficiency with the company&#39;s third-party manufacturing vendor. The vendor in question is a subcontractor to Unicycives contract manufacturer (CDMO) and provides mostly fill/finish services for manufacturing OLC. Management reported that other than this issue, the FDA has not identified any other safety, efficacy, or manufacturing issues with the NDA submission. 
 
H.C. Wainwright went on to say:

Fresenius Medical Care AG & Co. KGAA

 Buy-$12 and said "We are initiating coverage of Unicycive with a Buy rating and a $12/share 12-month Price Target" - "We estimate that OLC could capture >$1.3B in peak sales in the US within two years after launch in 2025" 


 
Lucid Capital additionally said in its initiation report:

@Quantumup …um it’s a phosphate binder.  It is no different than all the generic phosphate binders currently on the market. Absolute hard 0% chance this goes to $12/share.  In fact you are fucking idiot.

StockTwits for iOS

 …um it’s a phosphate binder.  It is no different than all the generic phosphate binders currently on the market. Absolute hard 0% chance this goes to $12/share.  In fact you are fucking idiot.